Phosphonic Acid

Phosphonic Acid

SCHEMBL222801

O=[PH](O)O.OP(O)(O)=S

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28427721 0.92 CA2 (0.31)
Phosphoric Acid SCHEMBL814222 0.76
Phosphoric Acid SCHEMBL15053704 0.76 CA2 (0.39)
Phosphoric Acid SCHEMBL10896983 0.76 CA2 (0.39)
Phosphoric Acid SCHEMBL28745250 0.76 CA2 (0.39)
Phosphonic Acid SCHEMBL3361675 0.75
SCHEMBL28461987 0.74 ALPG (0.31)
SCHEMBL992305 0.74 ALPG (0.31)
SCHEMBL277895 0.74 ALPG (0.31)
SCHEMBL29357 0.74 ALPG (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0845217-A1 Inhibiting undesirable taste in oral compositions THE PROCTER & GAMBLE COMPANY (US) 1998-06-03 EP claimed
US-20230338557-A1 ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF CODE BIOTHERAPEUTICS, INC. 2023-10-26 US disclosed
WO-2023154788-A2 ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF CODE BIOTHERAPEUTICS, INC. (US) 2023-08-17 WO disclosed
US-20230015276-A1 METHODS AND COMPOSITIONS TO INCREASE SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION CHILDREN'S MEDICAL CENTER CORPORATION (US) 2023-01-19 US disclosed
US-20220242964-A1 COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2022-08-04 US disclosed
US-11390885-B2 Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation CHILDREN'S MEDICAL CENTER CORPORATION (US) 2022-07-19 US disclosed
US-11147828-B2 Let-7 microRNA and mimetics thereof as therapeutics for cancer CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-10-19 US disclosed
US-11117976-B2 Compositions and methods for regulating erythropoiesis UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2021-09-14 US disclosed
EP-3258958-B1 COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RHINOVIRUS INFECTIONS UNIV VIRGINIA PATENT FOUNDATION (US) 2021-05-26 EP disclosed
US-10870854-B2 Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-12-22 US disclosed
WO-1999053961-A9 PEPTIDES FOR EFFICIENT GENE TRANSFER UNIV MICHIGAN (US) 2000-09-08 WO disclosed
WO-1999058640-A2 MCT-1, A HUMAN ONCOGENE PHILADELPHIA HEALTH AND EDUCATION CORPORATION (US) 1999-11-18 WO disclosed
WO-1999053903-A1 MICROSPHERES CONTAINING CONDENSED POLYANIONIC BIOACTIVE AGENTS AND METHODS FOR THEIR PRODUCTION THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1999-10-28 WO disclosed
WO-1999053961-A1 PEPTIDES FOR EFFICIENT GENE TRANSFER THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1999-10-28 WO disclosed
EP-0910301-A1 COMPOSITIONS AND METHODS FOR COATING MEDICAL DEVICES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1999-04-28 EP disclosed
EP-0845217-A1 Inhibiting undesirable taste in oral compositions THE PROCTER & GAMBLE COMPANY (US) 1998-06-03 EP disclosed
EP-0845217-A1 Inhibiting undesirable taste in oral compositions THE PROCTER & GAMBLE COMPANY (US) 1998-06-03 EP disclosed
WO-1997047254-A9 COMPOSITIONS AND METHODS FOR COATING MEDICAL DEVICES 1998-03-19 WO disclosed
WO-1997047254-A1 COMPOSITIONS AND METHODS FOR COATING MEDICAL DEVICES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1997-12-18 WO disclosed
US-4407765-A ACYLATION OF PHOSPHITE TRIESTER FOLLOWED BY REACTION WITH PHOSPHITE DIESTER STAUFFER CHEMICAL COMPANY (US) 1983-10-04 US disclosed